TL;DR
This study demonstrates that endovascular treatment (EVT)—mechanically removing blood clots—remains safe and effective for stroke patients even beyond the traditional 24-hour window. By using CT perfusion imaging to identify "salvageable" brain tissue rather than relying strictly on the clock, clinicians achieved functional recovery rates comparable to those treated within the standard 6–24 hour timeframe.
What Problem Does This Paper Address?
In the world of stroke neurology, "time is brain." For years, the window for endovascular treatment (EVT) was limited to 6 hours. Recent landmark trials (DAWN and DEFUSE-3) expanded this to 24 hours for patients with Large Vessel Occlusions (LVO) who show salvageable tissue on advanced imaging.
However, the "super late window"—beyond 24 hours—remains a "gray zone." Doctors worry about reperfusion injury (bleeding caused by restoring blood flow to dead tissue) and whether the procedure actually helps at that late stage. This paper investigates whether uniform imaging criteria (CT perfusion) can safely identify patients who will benefit from EVT even days after their stroke symptoms began.
Methods
The researchers conducted a retrospective study at a high-volume stroke center in China, analyzing patients treated between 2020 and 2023.
- Patient Selection: They used the DEFUSE-3 imaging criteria: an ischemic core (already dead tissue) < 70 mL and a significant "penumbra" (at-risk but salvageable tissue) identified via CT perfusion (CTP) and analyzed by RAPID software.
- Comparison Groups: They compared 82 patients treated after 24 hours (the "very late window") against a control group of 400 patients treated within 6–24 hours.
- Statistical Rigor: To ensure a fair comparison, they used Propensity Score Matching (PSM) at a 1:2 ratio, balancing the groups for age, sex, stroke severity (NIHSS score), and occlusion site.
- Procedure: Treatment included mechanical thrombectomy, often supplemented by emergency angioplasty or stenting (common in cases of underlying atherosclerosis).
Datasets
The study utilized a clinical dataset from a single center (Zhejiang Taizhou Hospital).
- Initial Screen: 1,116 patients.
- Final Cohort: 482 patients (400 in the 6–24h group; 82 in the >24h group).
- Post-Matching: 164 patients in the 6–24h group vs. 82 in the >24h group.
Key Insights and Ideas
- Tissue Over Time: The study reinforces the shift from a "time window" to a "tissue window." If the imaging shows salvageable brain, the chronological age of the stroke is less important.
- The "Slow Progressor" Phenotype: Patients in the >24h group had a much higher incidence of Large-Artery Atherosclerosis (LAA) (89% vs 75.6%). These patients often have better "collateral circulation" (backup blood vessels), which keeps brain tissue alive longer, making them ideal candidates for late intervention.
- Neurological Deterioration (ND) as a Trigger: A staggering 78% of the very late group experienced neurological worsening after arriving at the hospital. This suggests that "rescue EVT" for patients who decline under medical observation is a highly effective strategy.
- Gender Differences: Interestingly, male sex was a strong predictor of a good outcome (OR = 4.569). The authors suggest this warrants further study into physiological or hormonal differences in stroke progression.
Key Results
The study found no statistically significant difference in primary outcomes between the two groups:
- Functional Independence (mRS ≤ 2 at 90 days): 58.5% in the >24h group vs. 61.6% in the 6–24h group.
- Safety (Symptomatic Bleeding/sICH): 7.3% vs. 9.8%.
- Mortality: 2.4% vs. 3.0%.
Predictors of Success: In the >24h group, three factors independently predicted a good outcome:
- Lower preoperative NIHSS score (less severe initial symptoms).
- Male sex.
- Preoperative neurological deterioration (indicating the presence of unstable but salvageable tissue).
Limitations and Future Work
- Retrospective Nature: As an observational study, it cannot definitively prove causality like a randomized controlled trial (RCT).
- Single-Center Bias: The high prevalence of atherosclerosis in this specific Chinese population may not generalize to Western populations where cardioembolism (clots from the heart) is more common.
- No "Medical Only" Control: The study compared late EVT to early EVT, but not to patients who received only medication beyond 24 hours.
- Posterior Circulation Caution: While anterior strokes did well, the sample size for posterior circulation (e.g., basilar artery) was small, and mortality was higher in that subgroup, suggesting more research is needed there.
The authors conclude that while these results are promising, large-scale RCTs are necessary to officially change clinical guidelines for the "super late" window.
Summary updated